Effect of low-dose cyclosporin on plasma lipoproteins and markers of cholestasis in patients with psoriasis

Effect of low-dose cyclosporin on plasma lipoproteins and markers of cholestasis in patients with psoriasis

The benefits of using cyclosporin in organ transplantation to prevent graft rejection outweigh its potential disadvantages, but with the use of lowdose cyclosporin in relatively healthy individuals, such as those with psoriasis, the risk:benefit ratio is altered. The effects of low-dose cyclosporin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:QJM : An International Journal of Medicine 1995-02, Vol.88 (2), p.109-113
Hauptverfasser: EDWARDS, B.D., BHATNAGAR, D., MACKNESS, M.I., GOKAL, R., BALLARDIE, F.W., CHALMERS, R.J.G., DURRINGTON, P.N.
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers - blood
Cholestasis - blood
Cholesterol, LDL - blood
Cyclosporine - administration & dosage
Cyclosporine - therapeutic use
Drug Administration Schedule
Humans
Lipoproteins - blood
Liver Function Tests
Psoriasis - blood
Psoriasis - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The benefits of using cyclosporin in organ transplantation to prevent graft rejection outweigh its potential disadvantages, but with the use of lowdose cyclosporin in relatively healthy individuals, such as those with psoriasis, the risk:benefit ratio is altered. The effects of low-dose cyclosporin (
ISSN:0033-5614
1460-2725
1460-2393
1464-3855
1460-2393
DOI:10.1093/oxfordjournals.qjmed.a069031